A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). - Wikidata - wikimedia - TriplyDB

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

http://www.wikidata.org/entity/Q38376026

about

Review of evidence for use of antidepressants in bipolar depression Review of pharmacological treatment in mood disorders and future directions for drug development.Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview Treatment of bipolar disorder Animal models of bipolar mania: The past, present and future.Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders Towards the clinical implementation of pharmacogenetics in bipolar disorder.Analysis of Classes Used in the Treatment of Depression by Physician-reported Severity.Quetiapine for acute bipolar depression: a systematic review and meta-analysis Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial.Antidepressants for bipolar disorder: A meta-analysis of randomized, double-blind, controlled trials.Antidepressant treatment for acute bipolar depression: an update.Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis.A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder.Quetiapine: a pharmacoeconomic review of its use in bipolar disorder.Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis.Antipsychotics as antidepressants.Bipolar II compared with bipolar I disorder: baseline characteristics and treatment response to quetiapine in a pooled analysis of five placebo-controlled clinical trials of acute bipolar depression The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?Korean Medication Algorithm Project for Bipolar Disorder: third revision.Who will benefit from antidepressants in the acute treatment of bipolar depression? A reanalysis of the STEP-BD study by Sachs et al. 2007, using Q-learning The management of schizophrenia: focus on extended-release quetiapine fumarate.Management of bipolar depression Management of Bipolar II Disorder Pharmacotherapy of bipolar disorder with quetiapine: a recent literature review and an update Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.A randomized pilot study of psychotherapy and quetiapine for the acute treatment of bipolar II depression.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder.Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.

P2860

Q26824365-EE57BE0D-7323-4DBD-8050-871FCDEA9E8D Q26853509-49ED3DBE-2B2F-481E-B49F-E7C928C3E235 Q27009995-1B92706A-16C4-4275-A049-79634631C9AC Q27499305-0ED9289E-AE0C-4BA8-A150-7077AF9C1B0D Q28066714-73B4D035-5234-4529-8D4E-928F2CC4A6F3 Q28076935-4B421A98-7CE0-46DD-ADBE-7FBA295D5ADF Q28076943-0B622B0B-2F27-4780-87CB-920BDF00DD72 Q28077687-5C7F40EB-3DDE-4A6A-BCEC-613D675C11E2 Q28290437-CEA7FFF7-1364-4670-85E0-F52952C48D8A Q30357298-B64100EF-9E64-40EA-9810-A200A5FAAD11 Q30569917-3473889C-D744-493D-BE37-372E2B1B36B0 Q30583384-BC92E006-EA45-4991-8477-D34BE9AEC830 Q33688133-2B4259D2-C230-4E5A-87CC-77C701EB9BCE Q33765242-19794349-4329-49A2-BE05-512E6B354FA9 Q33829611-3ECF64CA-FBC8-4C04-9FFE-AB0ACE2CC2A4 Q34063590-E9512621-2D82-4D1D-9046-FE73EFB368E0 Q34095729-B79CC531-03DB-4718-BBCA-5773506674A4 Q34154885-6C973978-C654-47A6-9486-1B01E9315ACF Q34218568-3B9880A0-A59C-4D67-AE3A-FEBFCBE881F5 Q34260074-52AC9817-EFC1-408B-AA20-4E88291EB936 Q34272859-E4ABE931-0823-4309-A4A8-7EA0716F5CC5 Q34349641-487ED45B-5758-4B42-861D-D97341EC31DA Q34475987-F9337BAE-68EB-479C-9A7E-44DE2EAF4FAC Q34518033-3B3FBF33-8FAB-40C6-9EB6-14A7CEBFA8CA Q34649187-A227824B-0433-4E19-ABE8-D26BA352B4DA Q34676317-77BBF708-0CE1-40EF-97F8-079436B749BE Q34809427-E3C5B40D-90E1-430C-9BC1-3C07D74C868F Q35142737-EAFA0AC9-B29F-438A-8A6A-64DDDB124858 Q35252303-18975BA1-B584-4B09-B05C-64D36F3C1903 Q35327044-E585EEFE-0750-4CF6-89CE-A7CE41C76147 Q35365539-7FFFA002-16A0-493D-AE1B-FF46462F929A Q35365581-989D38A6-3A6D-4EF2-B0B9-36B88CBCF691 Q35579215-138730AA-16F1-4BFB-8B93-7E39B4305868 Q35772628-1608CDEF-41AB-42F2-B0D7-9CB5E7DF9D2E Q35831460-31B05A8A-43E8-4C1C-BCD9-0FBDAB7782CE Q35838572-38674B86-0955-4E5B-95BA-77409843DF0F Q35862776-9C284CA0-E686-40EB-B6ED-BC20E904DF65 Q36393992-C1E1EEA4-DC77-4B8B-99DB-0FD49450F0B6 Q36732869-E34EB043-88FD-4C8F-AFEA-2FF4652AF53F Q36806521-690639E0-9B0F-4123-9F62-0429F0E2425E

P2860

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

http://www.wikidata.org/entity/Q38376026

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

A double-blind, placebo-contro ...... olar depression (EMBOLDEN II).

@en

type

label

A double-blind, placebo-contro ...... olar depression (EMBOLDEN II).

@en

prefLabel

A double-blind, placebo-contro ...... olar depression (EMBOLDEN II).

@en

P1433

Q38376026-846033E5-4CC7-4346-8700-FEB0D4A31E56

P1476

Q38376026-9FC8D975-A749-44C1-BF3A-2AF47A5FCA68

P2093

Q38376026-21D0C27A-0EE2-493C-B5C3-BBE9AED5997A

Q38376026-27EBDE95-D824-4213-9BA0-F163108B7B71

Q38376026-453F9EFF-6142-418D-B876-17683D2816EF

Q38376026-4C6A1179-BAD9-482E-B580-B2536B4F46D5

Q38376026-71FBA601-E26B-4B02-ABEF-2ADDF348E7BA

Q38376026-75792064-D94C-42D2-A028-31142B9F8958

Q38376026-B4648F4D-9DB1-4CAD-9C18-E13EC76B356A

Q38376026-D1B12D07-0EF6-42E0-B060-2863A3A7EC6F

Q38376026-E10E547D-5C2F-4B4E-B502-7D5FA8B000B8

Q38376026-E2BB3F24-024D-400C-967A-DA04A637DE63

P304

Q38376026-63C29E81-C57D-4BF8-89F6-196B4E63DEF3

P31

Q38376026-7007951A-C7DE-44A9-B547-8C91C242E806

P356

Q38376026-914DA6C0-7BFD-4F83-831E-6F66567D8189

P433

Q38376026-D1B1DD98-9DE3-47F8-9D62-E0ECA31E2483

P478

Q38376026-6796F4D0-21EC-492D-ADD4-DD99B24B6658

P577

Q38376026-3A57C542-3A3D-47C1-BDA5-81EF7CC8748C

P698

Q38376026-1939D0C4-CCD5-419D-A789-701DDC18B087

P921

Q38376026-9E9FA6E8-38D4-45AC-A395-A80DBD1623C0

P356

JCP.08M04942GRE

P1433

The Journal of Clinical Psychiatry

P1476

A double-blind, placebo-contro ...... olar depression (EMBOLDEN II).

@en

P2093

Allan H Young

http://www.w3.org/2001/XMLSchema#string

Arvid Nordenhem

http://www.w3.org/2001/XMLSchema#string

Bengt Olausson

http://www.w3.org/2001/XMLSchema#string

Björn Paulsson

http://www.w3.org/2001/XMLSchema#string

Charles Merideth

http://www.w3.org/2001/XMLSchema#string

EMBOLDEN II (Trial D1447C00134) Investigators

http://www.w3.org/2001/XMLSchema#string

Martin Brecher

http://www.w3.org/2001/XMLSchema#string

Richard H Weisler

http://www.w3.org/2001/XMLSchema#string

Susan L McElroy

http://www.w3.org/2001/XMLSchema#string

Vasavan Agambaram

http://www.w3.org/2001/XMLSchema#string

P304

163-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4088/JCP.08M04942GRE

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20122366

http://www.w3.org/2001/XMLSchema#string

P921